日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Sex Disparities in Breast Cancer Survival According to Clinical Treatment Score Post-5 Years (CTS5) Risk Stratification

根据临床治疗评分（CTS5）风险分层分析乳腺癌生存率的性别差异

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2025.361
Liu, Ke; Lu, Zhen-Zhen; He, Zhen-Yu; Wu, San-Gang
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Association of lymph node ratio with adjuvant radiotherapy benefit in human papillomavirus-positive oropharyngeal squamous cell carcinoma: a population-based analysis

淋巴结比率与人乳头瘤病毒阳性口咽鳞状细胞癌辅助放疗获益的相关性：一项基于人群的分析

期刊:Infectious Agents and Cancer
影响因子:2.8
doi:10.1186/s13027-026-00744-9
Lu, Zhen-Zhen; Chen, Xin-Jia; You, Zi-Qing; Li, Yi-Min; Wu, San-Gang
微生物学
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Real-world treatment practices and survival outcomes of patients with de novo metastatic nasopharyngeal carcinoma after chemoimmunotherapy

真实世界中接受化疗免疫治疗的初发转移性鼻咽癌患者的治疗实践和生存结果

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04160-7
Lin, Qin; Zhou, Yuan; Guo, Lin-Feng; Lu, Guan-Zhong; Wu, San-Gang
鼻咽癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Induction Camrelizumab and Modified TPF (Nab-Paclitaxel, Cisplatin, and S-1) in Locoregionally Advanced Nasopharyngeal Carcinoma

局部晚期鼻咽癌的诱导治疗：卡瑞利珠单抗联合改良TPF方案（白蛋白结合型紫杉醇、顺铂和S-1）

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70037
Yu, Yi-Feng; Dai, Ya-Qing; Zhang, Zong-Kai; Lu, Guan-Zhong; Lin, Qin; Wu, San-Gang
鼻咽癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Reply to Commentary on "Metronomic S-1 Adjuvant Chemotherapy Improves Survival in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma"

对“节律性S-1辅助化疗可提高局部晚期鼻咽癌患者的生存率”一文的评论的回复

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2024.1048
Wu, San-Gang
鼻咽癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma?

局部晚期鼻咽癌需要进行两到三个疗程的诱导化疗吗？

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14699-4
Guo, Lin-Feng; Yu, Yi-Feng; Lu, Zhen-Zhen; Lin, Qin; Wu, San-Gang
鼻咽癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Patterns of failure and prognosis in nasopharyngeal carcinoma according to Epstein-Barr virus DNA status

根据 Epstein-Barr 病毒 DNA 状态分析鼻咽癌的失败模式和预后

期刊:Infectious Agents and Cancer
影响因子:2.8
doi:10.1186/s13027-024-00631-1
Guo, Lin-Feng; Lu, Guan-Zhong; Lu, Zhen-Zhen; Yu, Yi-Feng; Wu, San-Gang
鼻咽癌
肿瘤
肿瘤免疫
微生物学
发表日期：2025
文献求助 收藏

Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinoma

血浆中 Epstein-Barr 病毒 DNA 用于预测非角化性分化型鼻咽癌的治疗反应和疾病进展

期刊:Infectious Agents and Cancer
影响因子:2.8
doi:10.1186/s13027-025-00661-3
Lu, Guan-Zhong; Huang, Yun-Xia; Guo, Lin-Feng; Yu, Yi-Feng; Lu, Zhen-Zhen; Lin, Qin; Wu, San-Gang
鼻咽癌
肿瘤
肿瘤免疫
微生物学
发表日期：2025
文献求助 收藏

Metronomic chemotherapy in locoregionally advanced nasopharyngeal carcinoma with residual EBV-DNA after induction chemotherapy

诱导化疗后局部晚期鼻咽癌伴残余EBV-DNA的节拍化疗

期刊:Infectious Agents and Cancer
影响因子:2.8
doi:10.1186/s13027-025-00694-8
Guo, Lin-Feng; Gong, Liu-Yun; Lin, Qin; Wu, San-Gang
鼻咽癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Initial Treatment Strategies Show No Survival Difference in Early-Stage Salivary Gland Mucosa-Associated Lymphoid Tissue Lymphoma

早期唾液腺黏膜相关淋巴组织淋巴瘤的初始治疗策略未显示出生存差异

期刊:Journal of Multidisciplinary Healthcare
影响因子:2.4
doi:10.2147/JMDH.S538452
Yang, Shi-Ping; Zhu, Jing; Qiu, Xin-Yi; Hong, Zhi-Cong; Wu, San-Gang
淋巴瘤
发表日期：2025
文献求助 收藏